Ann: Appendix 3B, page-18

Hi Mrschemist,

Finally after 3 years, I finally entered RACE today, with a small parcel.

After reading the prospectus back in June 2016.

I was impressed with race and was about to buy some shares.

For some reason, I didn't buy into race at that time, as another stock caught my eye.

During the last 3 years, occasionally I would have a quick look at the share price.

I personal think that this drug Bisantrene can go a long way in helping very sick people.

Unfortunately the approval process takes a very long time and often share holders are frustrated, with the process in it self and also the share price.

For all share holders and especially the long timers who brought at the very beginning, have to be a little more patience.

To me the share price is getting close to the over sold range and then hope fully with good news it changes direction and heads back up.

Regards

Rossi70